In accordance with these findings, JQ1 treatment markedly decreased PARPi-induced phosphorylation of RPA32 which is a DNA end-resection marker, in MYC paralog-dependent SCLC cells (45). This evidence concerns the gene MYC and small cell lung carcinoma.